This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Affiliated Managers Group (AMG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AMGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Boston Scientific Climbs 40.5% in a Year: What's Driving the Stock?
by Zacks Equity Research
BSX rallies 40.5% in a year, fueled by WATCHMAN growth, MedSurg gains, acquisitions and global expansion efforts.
BSXPositive Net Change CAHPositive Net Change CORPositive Net Change PAHCPositive Net Change
medical medical-devices
Can ISRG Maintain Robotics Edge Amid Rising Rivalry & Budget Strain?
by Indrajit Bandyopadhyay
ISRG posted strong Q1 growth, but rising rivals and tighter hospital budgets test its robotics dominance and pricing power.
MDTPositive Net Change ISRGPositive Net Change GMEDNegative Net Change
medical medical-devices
Best Value Stocks to Buy for July 1st
by Zacks Equity Research
MITSY, NGD and PDEX made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 1, 2025.
MITSYPositive Net Change NGDPositive Net Change PDEXPositive Net Change
medical-devices
Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
by Moumi Mondal
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
UNHPositive Net Change NVONegative Net Change LLYPositive Net Change CVSPositive Net Change ELVNegative Net Change
medical medical-devices
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
by Debanjana Dey
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
HIMSPositive Net Change LFMDNegative Net Change
medical medical-devices
Should You Buy Digi Power X Inc. (DGXX) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
DGXXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Lumentum (LITE) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
LITEPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock
by Zacks Equity Research
TECH teams up with USP to boost mAb and gene therapy testing, aiming to simplify analytics and enhance product quality.
BSXPositive Net Change TECHNegative Net Change PAHCPositive Net Change HIMSPositive Net Change
medical medical-devices
SYK Boosts Foot & Ankle Portfolio With FDA-Cleared Total Ankle System
by Zacks Equity Research
Stryker expands its Foot & Ankle portfolio with FDA-cleared InCompass, targeting streamlined total ankle replacement.
SYKPositive Net Change CORPositive Net Change ITGRNegative Net Change HIMSPositive Net Change
medical medical-devices
Grupo Televisa (TV)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
TVPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy TSMC (TSM) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
TSMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Shoals Technologies Group (SHLS) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SHLSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
OneSpaWorld (OSW) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
OSWPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tempus AI's Data Business Keeps Scaling Up: Can the Growth Pace Last?
by Moumi Mondal
TEM is scaling fast; Data and Services revenues soar 43%, fueled by big-name pharma and AI model deals.
AZNNegative Net Change ICLRNegative Net Change IQVNegative Net Change TEMPositive Net Change
medical medical-devices
SNN Expands Orthopedic Portfolio With Advanced Tibia Nailing System
by Zacks Equity Research
Smith + Nephew launches TRIGEN MAX, the only tibia nailing system with side-specific nails for precise, low-impact fracture repair.
ANGOPositive Net Change SNNPositive Net Change CVSPositive Net Change ITGRNegative Net Change
medical medical-devices
Walgreens Q3 Earnings Top Estimates, Stock Up, Gross Margin Declines
by Zacks Equity Research
WBA tops Q3 earnings and sales estimates and lifts shares, but the gross margin contracts, and guidance is withdrawn.
ISRGPositive Net Change VEEVPositive Net Change WBANegative Net Change ITGRNegative Net Change
earnings medical medical-devices
Does DOCS' Shift Toward Enterprise Offerings Signal a Long-Term Pivot?
by Indrajit Bandyopadhyay
DOCS sharpens its enterprise focus with AI and workflow tools, signaling a deeper pivot beyond pharma marketing roots.
HSTMPositive Net Change AMWLNegative Net Change DOCSPositive Net Change
medical medical-devices
WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus
by Zacks Equity Research
West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.
ALGNNegative Net Change CAHPositive Net Change MCKPositive Net Change WSTPositive Net Change
medical medical-devices
Is the Options Market Predicting a Spike in Brainsway Stock?
by Zacks Equity Research
Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.
BWAYPositive Net Change
medical medical-devices
Reasons to Retain TransMedics Stock in Your Portfolio for Now
by Zacks Equity Research
TMDX continues to witness growth on the back of its strength in OCS technology and the National OCS Program.
ANGOPositive Net Change CVSPositive Net Change ITGRNegative Net Change TMDXPositive Net Change
medical medical-devices
Illumina Stock May Benefit From New Agreement to Acquire SomaLogic
by Zacks Equity Research
ILMN jumps 2.9% after striking a $350M deal to acquire SomaLogic and boost its fast-growing multiomics strategy.
ILMNPositive Net Change PAHCPositive Net Change HIMSPositive Net Change LABNegative Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in LivaNova Stock?
by Zacks Equity Research
Investors need to pay close attention to LivaNova stock based on the movements in the options market lately.
LIVNPositive Net Change
medical medical-devices
Salesforce vs. Veeva: Which Cloud CRM Stock Is the Smarter Buy?
by Anirudha Bhagat
VEEV's niche focus and strong margins give it an edge over CRM despite its higher valuation and smaller scale.
CRMPositive Net Change VEEVPositive Net Change
artificial-intelligence computers medical medical-devices software tech-stocks
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
by Zacks Equity Research
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.
CORPositive Net Change ITGRNegative Net Change HIMSPositive Net Change GEHCNegative Net Change
medical medical-devices